Novel Role for Glutathione S-Transferase Π
Danyelle M. Townsend,Yefim Manevich,Lin He,Steven Hutchens,Christopher J. Pazoles,Kenneth D. Tew
DOI: https://doi.org/10.1074/jbc.m805586200
IF: 5.485
2009-01-01
Journal of Biological Chemistry
Abstract:Glutathione S-transferase Pi (GSTπ) is a marker protein in many cancers and high levels are linked to drug resistance, even when the selecting drug is not a substrate. S-Glutathionylation of proteins is critical to cellular stress response, but characteristics of the forward reaction are not known. Our results show that GSTπ potentiates S-glutathionylation reactions following oxidative and nitrosative stress in vitro and in vivo. Mutational analysis indicated that the catalytic activity of GST is required. GSTπ is itself redox-regulated. S-Glutathionylation on Cys47 and Cys101 autoregulates GSTπ, breaks ligand binding interactions with c-Jun NH2-terminal kinase (JNK), and causes GSTπ multimer formation, all critical to stress response. Catalysis of S-glutathionylation at low pK cysteines in proteins is a novel property for GSTπ and may be a cause for its abundance in tumors and cells resistant to a range of mechanistically unrelated anticancer drugs. Glutathione S-transferase Pi (GSTπ) is a marker protein in many cancers and high levels are linked to drug resistance, even when the selecting drug is not a substrate. S-Glutathionylation of proteins is critical to cellular stress response, but characteristics of the forward reaction are not known. Our results show that GSTπ potentiates S-glutathionylation reactions following oxidative and nitrosative stress in vitro and in vivo. Mutational analysis indicated that the catalytic activity of GST is required. GSTπ is itself redox-regulated. S-Glutathionylation on Cys47 and Cys101 autoregulates GSTπ, breaks ligand binding interactions with c-Jun NH2-terminal kinase (JNK), and causes GSTπ multimer formation, all critical to stress response. Catalysis of S-glutathionylation at low pK cysteines in proteins is a novel property for GSTπ and may be a cause for its abundance in tumors and cells resistant to a range of mechanistically unrelated anticancer drugs. Glutathione S-transferases (GSTs) 2The abbreviations used are: GST, glutathione S-transferase; JNK, c-Jun NH2-terminal kinase; MALDI-TOF, matrix-assisted laser desorption ionization time-of-flight; NO, nitric oxide; MEF, mouse embryo fibroblasts; HEK, human embryonic kidney; CDNB, 1-chloro-2,4-dinitrobenzene; PBS, phosphate-buffered saline; WT, wild type; CD, circular dichroism; PABA, O2-{2,4-dinitro-5-[4-(N-methylamino)benzoyloxy]phenyl}1-(N,N-dimethylamino)diazen-1-ium-1,2-diolate. are classified as a family of Phase II detoxification enzymes that have classically been described as catalyzing the conjugation of glutathione (GSH) to electrophilic compounds through thioether linkages (1Boyland E. Chasseaud L.F. Biochem. J. 1967; 104: 95-102Crossref PubMed Scopus (268) Google Scholar). The Pi class (GSTπ) is present at high levels in many solid tumors (particularly ovarian, non-small cell lung, breast, liver, pancreas, colon, and lymphomas) and has been indicated in many reports to be overexpressed in drug-resistant tumors (2Tew K.D. Cancer Res. 1994; 54: 4313-4320PubMed Google Scholar, 3Hayes J.D. Pulford D.J. Crit. Rev. Biochem. Mol. Biol. 1995; 30: 445-600Crossref PubMed Scopus (3254) Google Scholar). Although its increased expression was frequently linked with enhancement of drug detoxification, in most instances the selecting drugs were not substrates of GSTπ. This ambiguity and the high prevalence of GSTπ in tumors have intimated cellular functions for the protein that are unrelated to catalytic detoxification. Recently GSTπ has been identified as an endogenous protein binding partner and regulator of c-Jun NH2-terminal kinase (JNK) and peroxiredoxin VI (1-cysPrx) (4Adler V. Yin Z. Fuchs S.Y. Benezra M. Rosario L. Tew K.D. Pincus M.R. Sardana M. Henderson C.J. Wolf C.R. Davis R.J. Ronai Z. EMBO J. 1999; 18: 1321-1334Crossref PubMed Scopus (962) Google Scholar, 5Wang T. Arifoglu P. Ronai Z. Tew K.D. J. Biol. Chem. 2001; 276: 20999-21003Abstract Full Text Full Text PDF PubMed Scopus (272) Google Scholar, 6Manevich Y. Feinstein S.I. Fisher A.B. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 3780-3785Crossref PubMed Scopus (293) Google Scholar). Moreover, oxidative stress causes increased GSTπ expression, the regulation of which has been identified as a downstream event linked to wild-type p53 function (7Lo H.W. Pleasants L. Cao X. Milas M. Pollock R. Ali-Osman F. Mol. Cancer Res. 2008; 6: 848-850Crossref Scopus (44) Google Scholar). Cellular response to oxidative or nitrosative stress includes S-glutathionylation, a post-translational modification characterized by conjugation of glutathione to low pK cysteine sulfhydryl or sulfenic acid moieties in target proteins. This adds a three-amino acid side chain and introduces a net negative charge (as a consequence of glutamic acid) to the protein (8Shelton M.D. Chock P.B. Mieyal J.J. Antioxid. Redox Signal. 2005; 7: 348-366Crossref PubMed Scopus (326) Google Scholar). Consequently, protection from further oxidative damage and/or alteration of protein conformation affecting function and/or cellular localization occurs. Proteins so far identified that are susceptible to S-glutathionylation can be categorized into six distinct clusters: cytoskeletal, glycolysis/energy metabolism, kinases and signaling pathways, calcium homeostasis, antioxidant enzymes, and protein folding (9Mack J.T. Beljanski V. Soulika A.M. Townsend D.M. Brown C.B. Davis W. Tew K.D. Mol. Cell. Biol. 2007; 27: 44-53Crossref PubMed Scopus (33) Google Scholar). Reversibility of S-glutathionylation spontaneously by GSH or catalytically by glutaredoxin or sulfiredoxin (8Shelton M.D. Chock P.B. Mieyal J.J. Antioxid. Redox Signal. 2005; 7: 348-366Crossref PubMed Scopus (326) Google Scholar, 10Beer S.M. Taylor E.R. Brown S.E. Dahm C.C. Costa N.J. Runswick M.J. Murphy M.P. J. Biol. Chem. 2004; 279: 47939-47951Abstract Full Text Full Text PDF PubMed Scopus (347) Google Scholar) 3Findlay, V. J., Townsend, D. M., Morris, T. E., Fraser, J. P., He, L., and Tew, K. D. (2006) Cancer Res. 66, 6800–6806 provides the cell with a dynamic cycle of regulatory events. A plausible link between GSTπ and such regulation was provided by the observation that GSTπ could conjugate glutathione to a member of the peroxiredoxin family, peroxiredoxin VI, a non-selenoglutathione-dependent peroxidase that converts lipids and other hydroperoxides to corresponding alcohols (6Manevich Y. Feinstein S.I. Fisher A.B. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 3780-3785Crossref PubMed Scopus (293) Google Scholar, 12Ralat L.A. Manevich Y. Fisher A.B. Colman R.F. Biochemistry. 2006; 45: 360-372Crossref PubMed Scopus (158) Google Scholar). The catalytically important cysteine residue on peroxiredoxin VI is sterically inaccessible for GSH within the globular homodimeric complex and GSTπ facilitated transfer of GS- to this site. The resultant activation of the enzyme served a cellular regulatory role through maintaining intracellular H2O2 levels (13Rhee S.G. Science. 2006; 312: 1882-1883Crossref PubMed Scopus (1718) Google Scholar), particularly with respect to antioxidant protection of cell membranes. Moreover, S-glutathionylation of protein-tyrosine phosphatase (PTP1B) or protein-disulfide isomerase inactivates these enzymes and can have impact on kinase-mediated proliferative events and protein folding (14Townsend D.M. Findlay V.J. Fazilev F. Ogle M. Fraser J. Saavedra J.E. Ji X. Keefer L.K. Tew K.D. Mol. Pharmacol. 2006; 69: 501-508Crossref PubMed Scopus (89) Google Scholar, 15Townsend D.M. Mol. Interv. 2007; 7: 313-324Crossref PubMed Scopus (173) Google Scholar). 3Findlay, V. J., Townsend, D. M., Morris, T. E., Fraser, J. P., He, L., and Tew, K. D. (2006) Cancer Res. 66, 6800–6806 Both endogenous and exogenous reactive oxygen and nitrogen species generation can cause S-glutathionylation of certain targeted proteins. For the present studies, we developed multiple model systems of oxidative and nitrosative stress to investigate the role of GSTs in S-glutathionylation reactions, using oxidized glutathione (GSSG) and two agents, NOV-002 and PABA/NO. NOV-002 is a mimetic of oxidized glutathione and causes oxidative stress induction (16Townsend D.M. He L. Hutchens S. VandenBerg T.E. Pazoles C.J. Tew K.D. Cancer Res. 2008; 68: 2870-2877Crossref PubMed Scopus (73) Google Scholar). PABA/NO (O2-{2,4-dinitro-5-[4-(N-methylamino)benzoyloxy]phenyl}1-(N,N-dimethylamino)diazen-1-ium-1,2-diolate) (17Saavedra J.E. Srinivasan A. Buzard G.S. Davies K.M. Waterhouse D.J. Inami K. Wilde T.C. Citro M.L. Cuellar M. Deschamps J.R. Parrish D. Shami P.J. Findlay V.J. Townsend D.M. Tew K.D. Singh S. Jia L. Ji X. Keefer L.K. J. Med. Chem. 2006; 49: 1157-1164Crossref PubMed Scopus (81) Google Scholar) is a prodrug, which releases nitric oxide (NO) and activates stress response pathways that involve JNK, eventually leading to apoptosis (14Townsend D.M. Findlay V.J. Fazilev F. Ogle M. Fraser J. Saavedra J.E. Ji X. Keefer L.K. Tew K.D. Mol. Pharmacol. 2006; 69: 501-508Crossref PubMed Scopus (89) Google Scholar, 18Findlay V.J. Townsend D.M. Saavedra J.E. Buzard G.S. Citro M.L. Keefer L.K. Ji X. Tew K.D. Mol. Pharmacol. 2004; 65: 1070-1079Crossref PubMed Scopus (109) Google Scholar). Elevated levels of NO provide the primary source of reactive nitrogen species and can alter protein function directly through post-translational modifications (nitration/nitrosylation) or indirectly through interactions with oxygen, superoxide, thiols, and heavy metals, the products of which can lead to S-glutathionylation. Recognition that S-glutathionylation of proteins and its cycling is important in regulating critical cellular events means that there is a need to define both the forward and reverse components of the cycle. Until this time, the forward reaction of S-glutathionylation has been tacitly assumed to occur spontaneously. Our present study shows for the first time that GSTπ catalyzes protein S-glutathionylation in vivo and is contributory to its high expression levels in many drug-resistant tumors. Materials and Cell Lines—Generation of GSTπ wild-type and knock-out mice (19Henderson C.J. Smith A.G. Ure J. Brown K. Bacon E.J. Wolf C.R. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 5275-5280Crossref PubMed Scopus (348) Google Scholar), extraction of the mouse embryo fibroblasts (MEF) cells, and details of the transfected NIH3T3 cell lines were described previously (20Rosario L.A. O'Brien M.L. Henderson C.J. Wolf C.R. Tew K.D. Mol. Pharmacol. 2000; 58: 167-174Crossref PubMed Scopus (51) Google Scholar, 21Ruscoe J.E. Rosario L.A. Wang T. Gate L. Arifoglu P. Wolf C.R. Henderson C.J. Ronai Z. Tew K.D. J. Pharmacol. Exp. Ther. 2001; 298: 339-345PubMed Google Scholar). Cell lines were maintained in Dulbecco's modified Eagle's medium containing 10% fetal calf serum, 100 μg/ml streptomycin, 100 units/ml penicillin, and 2 mm l-glutamine at 5% CO2 and 37 °C. GSH (reduced) and GSSG (oxidized) were obtained from MP Biomedicals (Aurora, OH). PABA/NO was prepared as previously described (14Townsend D.M. Findlay V.J. Fazilev F. Ogle M. Fraser J. Saavedra J.E. Ji X. Keefer L.K. Tew K.D. Mol. Pharmacol. 2006; 69: 501-508Crossref PubMed Scopus (89) Google Scholar). NOV-002 was provided by Novelos Therapeutics, Inc. (Newton, MA). Human GSTπ Mutagenesis—Human GSTπ was amplified using PCR from a cDNA prepared from HEK293 cells using the following oligonucleotides: 5′-GCGCGAATTCATGCCGCCCTACACCGTGGT-3′ and 5′-GCGCAAGCTTTCACTGTTTCCCGTTGCCAT-3′. The resulting PCR fragments were cloned into the EcoRI/HindIII recognition sites of pCMV2b FLAG tag vector for mammalian expression and into the NheI/BamHI recognition sites of pET28b for expression in Escherichia coli. Cysteines 47 and 101 were changed to alanine by site-directed mutagenesis using the kit supplied by Stratagene (La Jolla, CA). The catalytically inactive mutant was generated by a single mutation (Y7F) by site-directed mutagenesis. The integrity of the inserts was confirmed by sequence analysis. Transfected Cell Lines—HEK293 cells were transfected with pCMV2b vector containing human wild-type (HEK293-WT), C47A mutation (HEK-Cys47), C101A mutation (HEK-Cys101), or the catalytically impaired mutant GSTπ (HEK-Y7F) using the transfection agent, Lipofectamine (Sigma). Mock transfectants (HEK-VA) were generated by transfecting HEK293 cells with the pCMV2b empty vector. GSTπ Activity Assays—The specific enzyme activity was evaluated with the 1-chloro-2,4-dinitrobenzene (CDNB) substrate as previously described (22Boyland E. Chasseaud L.F. Adv. Enzymol. Relat. Areas Mol. Biol. 1969; 32: 173-219PubMed Google Scholar). 48 h after transfection, HEK293 cells were lysed and 100 μg of protein per reaction assayed. The reaction mixture was carried out in 100 mm PBS with 1.0 mm EDTA, pH 6.5, containing 1 mm GSH and CDNB. The absorbance at 340 nm was monitored every 30 s for 2 min in a Bio-Rad Benchmark Plus Microplate Spectrophotometer. The rate of spontaneous conjugation of GSH to CDNB was subtracted from the rates of GSTπ-catalyzed reactions. The extinction coefficient (5.3 m-1 cm-1) for the CDNB conjugate at 340 nm in 96-well plates was used to calculate the specific activity. Protein Preparation—Cells (5 × 105 per treatment group) were collected and washed with PBS. Cell pellets were suspended in lysis buffer containing 20 mm Tris-HCl, pH 7.5, 15 mm NaCl, 1 mm EDTA, 1 mm EGTA, 1% Triton X-100, 2.5 mm sodium pyrophosphate, and 1 mm glycerophosphate with freshly added phosphatase inhibitors (5 mm sodium fluoride and 1 mm Na3VO4) and a protease inhibitor mixture (Sigma). Cells were incubated for 30 min on ice, disrupted by sonication (3 times for 10 s), and centrifuged for 30 min at 10,000 × g (4 °C). Protein concentrations in the supernatant were determined with the Bradford method (Bio-Rad) using IgG as a standard. Immunoblot Analysis—Equivalent amounts of protein were electrophoretically resolved under non-reducing conditions on 10% SDS-polyacrylamide gels; unmodified proteins were separated under reducing conditions. Proteins were transferred onto nitrocellulose membranes (Bio-Rad). Nonspecific binding was reduced by incubating the membrane in blocking buffer (20 mm Tris-HCl, pH 7.5, 150 mm NaCl, 0.1% Tween 20, 1 μm protease inhibitors, 5 mm sodium fluoride, and 1 mm Na3VO4) containing 10% nonfat dried milk for 1 h. Membranes were incubated with the indicated antibody (blocking buffer containing 5% nonfat dried milk) overnight at 4 °C, washed 3 times with PBS for 15 min, and incubated with the appropriate secondary antibody conjugated to horseradish peroxidase for 1 h. The membranes were washed 3 times and developed with enhanced chemiluminescence detection reagents (Bio-Rad). The blots were scanned with a Bio-Rad ChemiDoc system and visualized with a transilluminator. The images were stored in a TIFF format. The relative intensity of bands was evaluated using Quantity One software (version 4.5.2; Bio-Rad) and plotted as arbitrary units in relation to actin. An infrared excited dual color (red and green) fluorescent imaging system (Odyssey LI-COR, NE) was used to detect S-glutathionylation of GSTπ (GST-SSG) in HEK293 cells after treatment with increasing amounts of PABA/NO. Proteins from cell lysates were resolved electrophoretically and transferred to polyvinylidene difluoride membranes as described above. Membranes were treated with proprietary blocking buffer (LI-COR, NE) and incubated with both polyclonal anti-GSTπ (1:1,000 dilution, Medical & Biological Laboratories Co., Ltd. (MDL), Nagoya, Japan) and monoclonal anti-glutathionylated protein antibodies (1:1,000 dilution, Virogen, Watertown, MA) as described above. After washing 3 times with PBS an immunoblot was developed with anti-rabbit IRDye®800CW (green) and anti-mouse IRDye®680 (red) secondary antibodies simultaneously (1:1,000 dilution, both from LI-COR, NE) according to the manufacturer's protocol. Finally, immunoblots were imaged with Odyssey imaging system (LI-COR) and quantified with standard software (LI-COR, NE). In Vivo Models—GSTπ wild-type (GSTP1P2+/+) and knock-out (GSTP1P2-/-) mice (4 and 12 weeks old) were housed in the Animal Resource Facility of the Medical University of South Carolina. Animal care was provided in accordance with the procedures outlined in the Guide for the Care and Use of Laboratory Animals (NIH Publication 86-23, 1985). Animals were treated with 5 mg/kg PABA/NO or 25 mg/kg NOV-002 by tail vein injection. Blood was collected in heparin-coated tubes by orbital bleed at various time points. The liver was harvested and protein lysates were prepared and immediately assayed for cysteine modification. Identification of S-Glutathionylated Serum Proteins—100 μg of control and drug-treated serum was separated by two-dimensional SDS-PAGE under non-reducing conditions. Proteins were resuspended in 8 m urea with 0.5% carrier ampholytes and run on immobilized pH gradients covering exponentially the pH range from 3 to 10. For the second dimension, the immobilized pH gradient strips were separated on 10% polyacrylamide gels. Protein spots of interest were excised and subject to trypsin digestion. Peptide mass was analyzed by MALDI-TOF mass spectrometry at the Proteomics Core Facility of the Medical University of South Carolina. Protein identification was performed using software from the National Center for Biotechnology Information protein data base. Detection of Protein Sulfhydryls in Liver Homogenates of GSTπ+/+ and GSTπ-/- Mice—The supernatants of liver homogenate (100 μl) were passed through a BioSpin6 (Bio-Rad) micro-column to eliminate both GSH and GSSG. Then 20 μl of eluent was added to 2 ml of 40 mm PB, pH 7.4, in a quartz cuvette of PTI QM-8 spectrofluorometer (PTI Inc., Birmingham, NJ) under constant stirring at 37 °C. The emission (513 nm, excitation at 379 nm) of each sample was recorded for 1 min (background) before and 2 min after an addition of 5 μm (final concentration) ThioGlo-1 (Calbiochem). Each sample fluorescence saturation value corresponds to a concentration of free sulfhydryls. At the end of each experiment 1 μm reduced glutathione was added to the sample to ensure that saturation was not associated with the concentration of ThioGlo-1. The data represent mean ± S.E. (SigmaStat 10, SyStat, MA) of at least three independent measurements per condition. Spectroscopic Analysis of GSTπ in Vitro—The effect of GSTπ S-glutathionylation on enzyme secondary structure was examined by circular dichroism (CD) where measurements were carried out on a 202 AVIV Associates (Lakewood, NJ) using a semimicro quartz rectangular 1 × 10 × 40-mm cuvette. GSTπ samples (>95% homogeneous, 40 μm in 20 mm PB, pH 7.4) were maintained at 22 °C using a Pelletier element. Spectra were recorded while scanning in the far-ultraviolet region (190–260 nm), with bandwidth of 1.0 nm, step size of 1.0 nm, integration time of 30 s, and three repeats. The output of the CD spectrometer was recalculated according to the protein concentration, amino acid content, and cuvette thickness into molecular ellipticity units (degrees/cm2/dmol). Protein tryptophan fluorescence was recorded on an F2500 spectrofluorometer (Hitachi) using 10 × 10 × 40-mm quartz cuvette, excitation and emission slits were 2.5 and 5.0 nm, respectively. GSTπ samples (>95% homogeneous, 1.0 μm in 20 mm PB, pH 7.4) before and after treatment with PABA/NO and GSH were used. The excitation wavelength was 295 nm to minimize an effect of protein tyrosines and phenylalanines. Background spectra were subtracted from final emission of the protein. GSTπ (∼2 mg/ml) was S-glutathionylated by treatment with 25 μm PABA/NO and 1 mm GSH for 10 min in 40 mm PB, pH 7.4, at room temperature. Excess PABA/NO and GSH were eliminated by triplicate washing through Biospin-6 (Bio-Rad) SEC micro-spin columns with 20 mm PBS. Protein concentration was determined by the Bradford method (Bio-Rad). Data Analysis—Mean ± S.D. for at least three experiments were calculated for each treatment group. The immunoblots shown are representative of at least three essentially identical results. Data were analyzed for statistically significant differences between the control and experimental/treated groups with Student's paired t test using SigmaStat 3.5 (Systat Software Inc., MA). Impact of GSTπ Phenotype on Protein S-Glutathionylation following Oxidative and Nitrosative Stress—The physiological importance of S-glutathionylation is established and becomes critical to cellular stress responses (for review see Refs. 15Townsend D.M. Mol. Interv. 2007; 7: 313-324Crossref PubMed Scopus (173) Google Scholar). The mechanism of this reaction has not been defined as spontaneous or enzymatically catalyzed. In the first model system, MEF derived from GSTπ wild-type (GSTP1P2+/+) and null (GSTP1/P2-/-) mice were used to evaluate the dynamics of S-glutathionylation following exposure to agents that induce either oxidative (e.g. GSSG) or nitrosative stresses (e.g. PABA/NO). Using monoclonal antibodies directed toward the S-glutathionylated moiety (Virogen, Watertown, MA), we observed a time- (Fig. 1) and dose- (Fig. 2) dependent increase in protein modification (PSSG) following oxidative (GSSG) and nitrosative (PABA/NO) stress in MEF-GSTπ+/+ cells. Under basal conditions, S-glutathionylated proteins were essentially undetectable in either MEF-GSTπ+/+ or MEF-GSTπ-/- cells. The quantification of experimental data from 3 immunoblots was averaged and the exponential rise to maximal was statistically analyzed using SigmaStat. The dose dependence of PABA/NO-induced S-glutathionylation elicits a sigmoidal shape only for GSTπ+/+ indicative of an enzyme-controlled process (Fig. 2, panel C). The lag period may be explained by the accumulation of PABA/NO active metabolite(s). The time-dependent kinetics of PABA/NO-induced S-glutathionylation are described by similar bell-shaped curves for both GSTπ+/+ and GSTπ-/- cells (Fig. 1, panel C), perhaps corresponding to the dynamic, reversible origin of S-glutathionylation. The S-glutathionylation of cellular proteins in GSTπ+/+ cells is higher, starts earlier, and lasts longer when compared with the GSTπ-/- cells, p < 0.01. These data suggest that whereas basal levels of S-glutathionylation may be spontaneous or catalyzed by other GSTs, GSTπ contributes significantly to its facilitation and amplification. The dose dependence of GSSG-induced S-glutathionylation shows the expected rise-to-maximum shape indicative of a direct effect of this drug. The presence of GSTπ results in significant amplification of this effect (Fig. 2, panel C). The kinetics of GSSG-induced S-glutathionylation was similar to those for PABA/NO (Fig. 1, panel C). A major difference is that the shorter period of maximal basal S-glutathionylation may correspond to a direct effect of oxidant stress or a direct involvement of glutathione reductase.FIGURE 2GSTπ expression enhances dose-dependent S-glutathionylation of proteins. Mouse embryo fibroblast cells derived from GSTπ+/+ or GSTπ-/- animals were treated with various concentrations of GSSG (A) or PABA/NO (B) for 1 h. Proteins were resolved by non-reducing SDS-PAGE and S-glutathionylation evaluated by immunoblot (IB) with PSSG antibody (n = 4). The kinetics of the S-glutathionylation reaction were analyzed using a standard 2-parameter exponential rise to maximum fitting procedure (Sigma Plot 10, SyStat, MA) for dose dependence following GSSG or PABA/NO (C) for GSTπ+/+ (•) and GST-/- MEF (▴). Data represent mean ± variance; p < 0.01.View Large Image Figure ViewerDownload Hi-res image Download (PPT) Nitrosative stress induced by PABA/NO treatment leads to S-glutathionylation of multiple proteins, 10 of which were identified in a prior report (14Townsend D.M. Findlay V.J. Fazilev F. Ogle M. Fraser J. Saavedra J.E. Ji X. Keefer L.K. Tew K.D. Mol. Pharmacol. 2006; 69: 501-508Crossref PubMed Scopus (89) Google Scholar). Total protein S-glutathionylation (e.g. proteins ranging from ∼30 to ∼200 kDa) was quantitated following a 25 μm PABA/NO treatment where there were 7-fold more in MEF-GSTπ+/+ compared with GSTπ-/- cells (307 ± 72 versus 44 ± 6 arbitrary units, p < 0.01) (Fig. 2). Maximal PABA/NO-induced S-glutathionylation of proteins in MEF-GSTπ+/+ cells was evident at 30 min, whereas MEF-GSTπ-/- cells had no detectable levels of modified proteins at this time (Fig. 1). Oxidative stress induced by GSSG treatment produced a dose- and time-dependent S-glutathionylation of a single 42-kDa protein that we previously identified as actin (14Townsend D.M. Findlay V.J. Fazilev F. Ogle M. Fraser J. Saavedra J.E. Ji X. Keefer L.K. Tew K.D. Mol. Pharmacol. 2006; 69: 501-508Crossref PubMed Scopus (89) Google Scholar). Maximal S-glutathionylation of actin was detected at 300 μm GSSG (Fig. 2), was 1.8-fold higher in MEF-GSTπ+/+ (p < 0.01), and occurred maximally at 15 min compared with 1 h for MEF-GSTπ-/- cells. Individual globular actin (G-actin) subunits polymerize to form filamentous actin (F-actin). S-Glutathionylation of G-actin subunits prevents its polymerization, and decreases both stress fiber and focal contact formation. We examined the morphological effects of GSSG-induced S-glutathionylated actin in MEF-GSTπ+/+ or MEF-GSTπ-/- cells. Phalloidin staining shows that in MEF-GSTπ+/+ there is a decrease in formation of both stress fibers and focal contacts (Fig. 3) compared with MEF-GSTπ-/- cells. These morphological data are quite consistent with enhanced S-glutathionylation of cellular G-actin as a consequence of GSTπ. GSTπ-/- Mice Have Reduced Levels of an S-Glutathionylated Serum Protein, Contrapsin, following Drug Treatment—One- and three-month-old male GSTP1P2+/+ and GST1P2-/- mice were used as an in vivo model to evaluate GST-mediated S-glutathionylation of serum and liver proteins. Mice were treated with a single dose of either 5 mg/kg PABA/NO or 25 mg/kg NOV-002 (Fig. 4, panel A). NOV-002 treatment leads to enhanced S-glutathionylation of contrapsin in serum in a dose- and time-dependent manner. S-Glutathionylation of contrapsin was evaluated in serum 1 h following treatment. The averaged relative density of S-glutathionylated contrapsin bands (Fig. 4, panel B) following PABA/NO and NOV-002 treatment at 1 h was significantly higher in GSTP1P2+/+ mice compared with GSTP1P2-/- (n = 6, p < 0.01). Analysis of Cysteine Modification in Liver Tissue—The fluorescent probe, ThioGlo-1 specifically reacts with sulfhydryls (e.g. unmodified cysteine residues) and was used to assess hepatic proteins following PABA/NO and NOV-002 treatment in 3-month-old GSTP1P2+/+ and GST1P2-/- mice (Fig. 4, panel C). Reduced ThioGlo-1 emission corresponding with decreased protein sulfhydryl concentration (e.g. cysteine modification) was observed following PABA/NO and NOV-002 treatment in the liver homogenates of GSTP1P2+/+ mice (control, 16,152 ± 509; NOV-002, 15,155 ± 352; PABA/NO, 12,583 ± 476, p < 0.001). Protein sulfhydryl modification in the liver was greater for the PABA/NO-treated (∼22%) versus NOV-002-treated (∼6%) animals (n = 3, p < 0.001). These data are consistent with immunoblot analysis showing a large number of S-glutathionylated cellular proteins following PABA/NO treatment, whereas oxidized glutathione treatment led to S-glutathionylation of actin. However, no statistical differences were detected in the liver lysate from GSTP1P2-/- mice following treatment. Our data indicate that GSTπ expression quantitatively influences oxidative/nitrosative stress-mediated protein S-glutathionylation in vivo. The Enzymatic Activity of GSTπ Is Crucial for Protein S-Glutathionylation in Vivo—The third model system was designed to test if the enzymatic activity of GSTπ is required for S-glutathionylation reactions. HEK293 cells were transfected with either wild-type (HEK-WT) or a catalytically inactive mutant (23Dirr H. Reinemer P. Huber R. Eur. J. Biochem. 1994; 220: 645-661Crossref PubMed Scopus (387) Google Scholar) (HEK-Y7F) of GSTπ. To validate the model system, a general GST substrate (CDNB) was used to measure the specific activity (Table 1). Mock-transfected cells (HEK-VA) had GST specific activity of 59 ± 3 units/mg, whereas HEK-WT cells were significantly higher (75 ± 2 units/mg; p < 0.01). The specific activity of GST was significantly reduced in HEK-Y7F cells (12 ± 5 units/mg; p < 0.01), presumably as a consequence of a dominant negative effect (the catalytic activity of GST is attributed to the dimeric form). Residual activity can be attributed to other isoforms of GST present in HEK293 cells. This model system was then used to demonstrate that GSTπ activity caused the observed dose- and time-dependent increase in protein S-glutathionylation (Fig. 5). The dose-dependent studies demonstrated that at 15 μm PABA/NO, the amount of S-glutathionylated proteins following treatment was substantially higher in HEK-WT cells as compared with untreated controls (p < 0.05); whereas HEK-VA and HEK-Y7F were equivalent to untreated controls. The dose dependence of PABA/NO-induced S-glutathionylation in this model system (Fig. 5, panel C) shows similar kinetics as in MEF cells. The presence of enzymatically active GSTπ dramatically amplified S-glutathionylation. Temporal differences in S-glutathionylation patterns were also observed following a single dose of 50 μm PABA/NO (Fig. 5, panel B). Within 5 min, the relative levels of S-glutathionylation were saturated in HEK-WT cells (389 ± 12 arbitrary units, p < 0.001), whereas HEK-VA and HEK-Y7F cells were essentially equivalent to untreated controls (82 ± 9 and 63 ± 9 arbitrary units, p > 0.05). The HEK-Y7F cells (catalytically impaired GSTπ) had S-glutathionylation patterns that were below HEK-VA, suggesting a dominant negative effect. Kinetic differences of the HEK-293 model system (Fig. 5,
What problem does this paper attempt to address?
-
Abstract 4061: Depleting the cellular level of glutathione and subsequently<i>S</i>-glutathionylation of keap1 by electrophilic agents activates keap1-nrf2 pathway
Xiaoyu Zhang,Zhongjun Ma,Fang Sun,Liming Shen
DOI: https://doi.org/10.1158/1538-7445.am10-4061
2010-01-01
Cellular and Molecular Biology
Abstract:Abstract S-glutathionylation is a reversible post-translational modification of protein cysteine with critical roles in oxidative stress and signal transduction. Keap1-Nrf2 pathway has emerged as a master regulator for the endogenous antioxidant response, which is critical in defending cells against carcinogenesis. Herein, we demonstrated that after depleting the cellular level of glutathione (GSH) by electrophilic agent (the GSH level decreased to 23 percent of control after the agent treatment for 4 h), Keap1 was modified by S-glutathionylation and Nrf2 expression increased both in nucleus and total cellular homogenates. The modification could be blocked by the addition of exogenous GSH, suggesting depleting the cellular level of GSH and alteration of intracellular GSH/GSSG ratio might be essential for S-glutathionylation of Keap1 and activating Keap1-Nrf2 pathway. Flexidock program was employed to elucidate the influence of Keap1 S-glutathionylation on Keap1-Nrf2 complex. After enforcing a disulfide bond between GSH and Cys434 residue in Keap1 and energy minimization, the two carboxylate oxygen atoms of GSH participate in hydrogen bond interaction with Arg483 and Arg380 residues in Keap1, which had been previously verified bound to DxETGE motif of Nrf2. The distance between GSH O1 and Arg483 NH1, GSH O2 and Arg380 NH1 were 2.587 Å and 2.569 Å, respectively, which could form potent hydrogen bonds and diminish the interaction between Keap1 and Nrf2, resulting in the accumulation of Nrf2 in the nucleus. We concluded from our findings that the activation of Keap1-Nrf2 pathway was triggered by Keap1 S-glutathionylation and conjugation with intracellular GSH might be a key event involved in the Nrf2 inducing activities of electrophilic agents. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 4061.
-
Abstract 4061: Depleting the cellular level of glutathione and subsequently S -glutathionylation of keap1 by electrophilic agents activates keap1-nrf2 pathway
liming shen,xiaoyu zhang,zhongjun ma,fang sun
DOI: https://doi.org/10.1158/1538-7445.am10-4061
IF: 11.2
2014-01-01
Cancer Research
Abstract:S-glutathionylation is a reversible post-translational modification of protein cysteine with critical roles in oxidative stress and signal transduction. Keap1-Nrf2 pathway has emerged as a master regulator for the endogenous antioxidant response, which is critical in defending cells against carcinogenesis. Herein, we demonstrated that after depleting the cellular level of glutathione (GSH) by electrophilic agent (the GSH level decreased to 23 percent of control after the agent treatment for 4 h), Keap1 was modified by S-glutathionylation and Nrf2 expression increased both in nucleus and total cellular homogenates. The modification could be blocked by the addition of exogenous GSH, suggesting depleting the cellular level of GSH and alteration of intracellular GSH/GSSG ratio might be essential for S-glutathionylation of Keap1 and activating Keap1-Nrf2 pathway. Flexidock program was employed to elucidate the influence of Keap1 S-glutathionylation on Keap1-Nrf2 complex. After enforcing a disulfide bond between GSH and Cys434 residue in Keap1 and energy minimization, the two carboxylate oxygen atoms of GSH participate in hydrogen bond interaction with Arg483 and Arg380 residues in Keap1, which had been previously verified bound to DxETGE motif of Nrf2. The distance between GSH O1 and Arg483 NH1, GSH O2 and Arg380 NH1 were 2.587 A and 2.569 A, respectively, which could form potent hydrogen bonds and diminish the interaction between Keap1 and Nrf2, resulting in the accumulation of Nrf2 in the nucleus. We concluded from our findings that the activation of Keap1-Nrf2 pathway was triggered by Keap1 S-glutathionylation and conjugation with intracellular GSH might be a key event involved in the Nrf2 inducing activities of electrophilic agents. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 4061.
-
Microsomal Glutathione Transferase 1 is Not S-nitrosylated in Rat Liver Microsomes or in Endotoxin Challenged Rats
Q Shi,YJ Lou
DOI: https://doi.org/10.1016/j.phrs.2004.10.001
IF: 10.334
2005-01-01
Pharmacological Research
Abstract:In vitro activation of purified rat microsomal glutathione transferase 1 (MGST1) by S-nitrosylation has been recently reported. This study was designated to explore its in vivo relevance. Unexpectedly, we failed to detect S-nitrosylated MGST1 in rat liver microsomes treated with S-nitrosoglutathione (GSNO); neither did we observe MGST1 S-nitrosylation in endotoxin challenged rats. However, by using matrix-assisted laser dissociation/ionization time-of-flight mass spectrometry (MALDI-TOF MS), we identified several other proteins which are susceptible to S-nitrosylation in liver microsomes, including retinol dehydrogenase type I (RODH I), aldolase B, cytochrome P4502C11, and peroxiredoxin 1. Our results suggest that MGST1 S-nitrosylation is unlikely to be involved in the protection mechanism against nitrosative stress caused by endotoxin challenge. Further studies on the novel S-nitrosylable microsomal proteins are also warranted.
-
The Multifaceted Role of Glutathione S-Transferases in Health and Disease
Aslam M. A. Mazari,Leilei Zhang,Zhi-Wei Ye,Jie Zhang,Kenneth D. Tew,Danyelle M. Townsend
DOI: https://doi.org/10.3390/biom13040688
IF: 6.064
2023-04-19
Biomolecules
Abstract:In humans, the cytosolic glutathione S-transferase (GST) family of proteins is encoded by 16 genes presented in seven different classes. GSTs exhibit remarkable structural similarity with some overlapping functionalities. As a primary function, GSTs play a putative role in Phase II metabolism by protecting living cells against a wide variety of toxic molecules by conjugating them with the tripeptide glutathione. This conjugation reaction is extended to forming redox sensitive post-translational modifications on proteins: S-glutathionylation. Apart from these catalytic functions, specific GSTs are involved in the regulation of stress-induced signaling pathways that govern cell proliferation and apoptosis. Recently, studies on the effects of GST genetic polymorphisms on COVID-19 disease development revealed that the individuals with higher numbers of risk-associated genotypes showed higher risk of COVID-19 prevalence and severity. Furthermore, overexpression of GSTs in many tumors is frequently associated with drug resistance phenotypes. These functional properties make these proteins promising targets for therapeutics, and a number of GST inhibitors have progressed in clinical trials for the treatment of cancer and other diseases.
biochemistry & molecular biology
-
Modeling the metabolic competency of glutathione S-transferases using genetically modified cell lines
Alan J Townsend,Sandra L Kabler,Johannes Doehmer,Charles S Morrow
DOI: https://doi.org/10.1016/s0300-483x(02)00294-9
IF: 4.571
2002-12-27
Toxicology
Abstract:Certain chemopreventive agents are thought to work in part via induction of GST expression. We have utilized transgenic cell lines to show that GST expression can protect against DNA alkylation, and in some cases cytotoxicity caused by electrophilic carcinogens conjugated by GSTs (e.g. 4-NQO, B[a]P, DiB[a,l]P, AFB(1), and certain drugs). However, factors governing protection by GST are complex and vary with different agents and end-points. For example, expression of GST alone was sufficient for partial protection against DNA alkylation by 4-NQO, but protection against 4-NQO cytotoxicity was only observed when the ATP-dependent GS-X transport protein MRP1 was also co-expressed. The dynamic competition between activation and detoxification is the focus of current studies in cells that co-express both CYP1A1 and either hGSTP1 or hGSTM1. Expression of hGSTP1 largely blocked B[a]P toxicity induced via the moderate activation by rat or human CYP1A1. With DiB[a,l]P, GSTs gave up to 7-fold protection against toxicity only when activated by human CYP1A1. However, cells with CYP1A1+GST remained at least 20-fold more sensitive to DiB[a,l]P than parent cells lacking either activity, due to strong activation by hCYP1A1. In summary, we have found that protection by GSTs against B[a]P or DiB[a,l]P toxicity is highly variable depending on differences in: (a) the PAH structure; (b) the human vs. rat CYP1A1 expressed; (c) GST isozyme(s) expressed; (d) cellular expression of conjugate transporters; or (e) DNA damage versus cytoxicity end-points.
-
Glutathione S-Transferase P Elicits Protection Against H2o2-Induced Cell Death Via Coordinated Regulation of Stress Kinases
ZM Yin,VN Ivanov,H Habelhah,K Tew,Z Ronai
DOI: https://doi.org/10.7916/d8571b9j
2000-01-01
Abstract:To elucidate mechanisms underlying glutathione S-transferase p (GSTp)-mediated cellular protection against oxidative stress-induced cell death, the effect of GSTp on stress signaling pathways was investigated before and after H2O2 treatment. Under nonstressed conditions, increased expression of GSTp via a tet-off-inducible GSTp in NIH 3T3 cells increased the phosphorylation of mitogen-activated protein (MAP) kinase kinase 4, p38, extracellular receptor kinase (ERK), and inhibitor of kappa-kinase (IKK), and reduced phosphorylation of MAP kinase kinase 7 and Jun NH2-terminal kinase (JNK). Whereas H2O2 treatment of cells induced JNK, p38, and IKK activities, in the presence of H2O2 and elevated GSTp expression there was an additional increase in ERK, p38, and IKK activities and a decrease in JNK activity. GSTp-mediated protection from H2O2-induced death was attenuated upon inhibition of p38, nuclear factor KB, or MAP kinase by dominant negative or pharmacological inhibitors. Conversely, expression of a dominant negative JNK protected cells from H2O2-mediated death. These data suggest that the coordinated regulation of stress kinases by GSTp, as reflected by increased p38, ERK, and nuclear factor kappaB activities together with suppression of JNK signaling, contributes to protection of cells against reactive oxygen species-mediated death.
-
Kinetic Behavior of Glutathione Transferases: Understanding Cellular Protection from Reactive Intermediates
Ralf Morgenstern
DOI: https://doi.org/10.3390/biom14060641
IF: 6.064
2024-05-30
Biomolecules
Abstract:Glutathione transferases (GSTs) are the primary catalysts protecting from reactive electrophile attack. In this review, the quantitative levels and distribution of glutathione transferases in relation to physiological function are discussed. The catalytic properties (random sequential) tell us that these enzymes have evolved to intercept reactive intermediates. High concentrations of enzymes (up to several hundred micromolar) ensure efficient protection. Individual enzyme molecules, however, turn over only rarely (estimated as low as once daily). The protection of intracellular protein and DNA targets is linearly proportional to enzyme levels. Any lowering of enzyme concentration, or inhibition, would thus result in diminished protection. It is well established that GSTs also function as binding proteins, potentially resulting in enzyme inhibition. Here the relevance of ligand inhibition and catalytic mechanisms, such as negative co-operativity, is discussed. There is a lack of knowledge pertaining to relevant ligand levels in vivo, be they exogenous or endogenous (e.g., bile acids and bilirubin). The stoichiometry of active sites in GSTs is well established, cytosolic enzyme dimers have two sites. It is puzzling that a third of the site's reactivity is observed in trimeric microsomal glutathione transferases (MGSTs). From a physiological point of view, such sub-stoichiometric behavior would appear to be wasteful. Over the years, a substantial amount of detailed knowledge on the structure, distribution, and mechanism of purified GSTs has been gathered. We still lack knowledge on exact cell type distribution and levels in vivo however, especially in relation to ligand levels, which need to be determined. Such knowledge must be gathered in order to allow mathematical modeling to be employed in the future, to generate a holistic understanding of reactive intermediate protection.
biochemistry & molecular biology
-
Glutathione S-transferase: A versatile and dynamic enzyme
Chinyere Aloke,Olalekan Olugbenga Onisuru,Ikechukwu Achilonu
DOI: https://doi.org/10.1016/j.bbrc.2024.150774
2024-11-19
Abstract:The dynamic and versatile group of enzymes referred to as glutathione S-transferases (GSTs) play diverse roles in cellular detoxification, safeguarding hosts from oxidative damage, and performing various other functions. This review explores different classes of GST, existence of polymorphisms in GST, functions of GST and utilizations of GST inhibitors in treatment of human diseases. The study indicates that the cytosolic GSTs, mitochondrial GSTs, microsomal GSTs, and bacterial proteins that provide resistance to Fosfomycin are the major classes. Given a GST, variation in its expression and function among individuals is due to the presence of polymorphic alleles that encode it. Genetic polymorphism might result in the modification of GST activity, thereby increasing individuals' vulnerability to harmful chemical compounds. GSTs have been demonstrated to play a regulatory function in cellular signalling pathways through kinases, S-Glutathionylation, and in detoxification processes. Various applications of bacterial GSTs and their potential roles in plants were examined. Targeting GSTs, especially GSTP1-1, is considered a potential therapeutic strategy for treating cancer and diseases linked to abnormal cell proliferation. Their role in cancer cell growth, differentiation, and resistance to anticancer agents makes them promising targets for drug development, offering prospects for the future.
-
[The Effects of Cysteines on the Function of Human Glutathion S-transferase Pi(gstp) under Cell Oxidative Stress].
Jian Sima,Lan He,Jian Zhu,Bin Xue,Yi Lin Tai,Shuang Quan Zhang,Zhi Min Yin
2004-01-01
Abstract:Site-directed mutagenesis was used to generate three cysteine mutants of GSTp, C(47/101), C(14/47/101) and C(14/47/101/169). GSTp, C(47/101), C(14/47/101) and C(14/47/101/169) were transfected into 293 cells separately and GST activity was determined by using CDNB as substrate. Data showed that each cysteine mutant inhibited endogenous GST catalyzatic activity and had remarkable dominant negative effect. The expression vectors of wide type GSTp and its cysteine mutants were co-transfected with c-Jun, NF-kappaB, or p21 luciferase reporting vector, into 293 cells separately, luciferase activity showed that C(14/47/101) and C(14/47/101/169) can dramatically activate c-Jun and p21 transcriptional activity. Each cysteine mutant can increase endogenous p21 level, and also increased mortality rate of 293 cells when exposed to H2O2. These results suggest that cysteine residues of GSTp play an important role in protecting cells against oxitative stress.
-
What Role Do Glutathione S-transferases Play in the Cellular Response to Ionizing Radiation?
A CHOLON,AJ GIACCIA,AD LEWIS,I HICKSON,JM BROWN
DOI: https://doi.org/10.1016/0360-3016(92)90519-n
1992-01-01
Abstract:The glutathione S-transferases (GST's) are cytosolic dimeric proteins that are composed of three family members, alpha, pi, and mu, and a fourth microsomal member. These four family members are primarily involved in cellular detoxification of xenobiotics and hydroperoxides. Recently, a strong correlation has been found between the overexpression of GST's and resistance to chemotherapeutic drugs. In comparison to chemotherapy, little is known about the role of GST's in the cellular response to ionizing radiation. To determine which GST's may be involved in this response, we have identified Chinese hamster ovary cell lines that possess different levels of alpha and pi GST isozyme activity. The survival of these cell lines to ionizing radiation was similar to that of wild-type Chinese hamster ovary-KI cells from which they were derived. Although differences in GST levels did not affect ionizing radiation sensitivity per se, we found that ionizing radiation decreased the amount of cytosolic pi GST without affecting alpha GST levels. Taken together, these data suggest that GST's are involved in the cellular response against oxidative stress generated by ionizing radiation.
-
The Key Role of GSH in Keeping the Redox Balance in Mammalian Cells: Mechanisms and Significance of GSH in Detoxification via Formation of Conjugates
Sofia K Georgiou-Siafis,Asterios S Tsiftsoglou
DOI: https://doi.org/10.3390/antiox12111953
2023-11-01
Abstract:Glutathione (GSH) is a ubiquitous tripeptide that is biosynthesized in situ at high concentrations (1-5 mM) and involved in the regulation of cellular homeostasis via multiple mechanisms. The main known action of GSH is its antioxidant capacity, which aids in maintaining the redox cycle of cells. To this end, GSH peroxidases contribute to the scavenging of various forms of ROS and RNS. A generally underestimated mechanism of action of GSH is its direct nucleophilic interaction with electrophilic compounds yielding thioether GSH S-conjugates. Many compounds, including xenobiotics (such as NAPQI, simvastatin, cisplatin, and barbital) and intrinsic compounds (such as menadione, leukotrienes, prostaglandins, and dopamine), form covalent adducts with GSH leading mainly to their detoxification. In the present article, we wish to present the key role and significance of GSH in cellular redox biology. This includes an update on the formation of GSH-S conjugates or GSH adducts with emphasis given to the mechanism of reaction, the dependence on GST (GSH S-transferase), where this conjugation occurs in tissues, and its significance. The uncovering of the GSH adducts' formation enhances our knowledge of the human metabolome. GSH-hematin adducts were recently shown to have been formed spontaneously in multiples isomers at hemolysates, leading to structural destabilization of the endogenous toxin, hematin (free heme), which is derived from the released hemoglobin. Moreover, hemin (the form of oxidized heme) has been found to act through the Kelch-like ECH associated protein 1 (Keap1)-nuclear factor erythroid 2-related factor-2 (Nrf2) signaling pathway as an epigenetic modulator of GSH metabolism. Last but not least, the implications of the genetic defects in GSH metabolism, recorded in hemolytic syndromes, cancer and other pathologies, are presented and discussed under the framework of conceptualizing that GSH S-conjugates could be regarded as signatures of the cellular metabolism in the diseased state.
-
Differential Catalytic Efficiency of Allelic Variants of Human GlutathioneS-Transferase Pi in Catalyzing the Glutathione Conjugation of Thiotepa,
S K Srivastava,S S Singhal,X Hu,Y C Awasthi,P Zimniak,S V Singh
DOI: https://doi.org/10.1006/abbi.1999.1217
IF: 4.114
1999-01-01
Archives of Biochemistry and Biophysics
Abstract:Alkylating agents are extensively used in the treatment of cancer. The clinical usefulness of this class of anticancer drugs, however, is often limited by the emergence of drug-resistant tumor cells. Increased glutathione (GSH) conjugation through catalysis by GSH S-transferases (GSTs) is believed to be an important mechanism in tumor cell resistance to alkylating agents. In the present study, we report that the allelic variants of human Pi class GST (hGSTP1-1), which differ: in their primary structures at amino acids in positions 104 and/or 113, exhibit significant differences in their activity in the GSH conjugation of alkylating anticancer drug thiotepa. Mass spectrometry revealed that the major product of the reaction between thiotepa and GSH was the monoglutathionyl-thiotepa conjugate. While nonenzymatic formation of monoglutathionyl-thiotepa was negligible, the formation of this conjugate was increased significantly in the presence of hGSTP1-1 protein. The hGSTP1-1-catalyzed GSH conjugation of thiotepa was time and protein dependent and followed Michaelis-Menten kinetics. The catalytic efficiency of hGSTP1-1(I104,A113) variant was approximately 1.9- and 2.6-fold higher compared with hGSTP1-1(V104,A113) and hGSTP1-1(V104,V113) isoforms, respectively. The results of the present study indicate that the hGSTP1-1 polymorphism may be an important factor in GST-mediated tumor cell resistance to thiotepa, and that subjects homozygous for the hGSTP1-1(I104,A113) allele, which is most frequent in human populations, are likely to be at a greater risk for developing GST-mediated resistance to thiotepa than heterozygotes or homozygotes with valine 104 background. (C) 1999 Academic Press.
-
Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity.
Huali Zhang,Pattraranee Limphong,Joel Pieper,Qiang Liu,Christopher K Rodesch,Elisabeth Christians,Ivor J Benjamin
DOI: https://doi.org/10.1096/fj.11-199869
2012-01-01
Abstract:To investigate the effects of the predominant nonprotein thiol, glutathione (GSH), on redox homeostasis, we employed complementary pharmacological and genetic strategies to determine the consequences of both loss-and gain-of-function GSH content in vitro. We monitored the redox events in the cytosol and mitochondria using reduction-oxidation sensitive green fluorescent protein (roGFP) probes and the level of reduced/oxidized thioredoxins (Trxs). Either H2O2 or the Trx reductase inhibitor 1-chloro-2,4-dinitrobenzene (DNCB), in embryonic rat heart (H9c2) cells, evoked 8 or 50 mV more oxidizing glutathione redox potential, E-hc (GSSG/2GSH), respectively. In contrast, N-acetyl-L-cysteine (NAC) treatment in H9c2 cells, or overexpression of either the glutamate cysteine ligase (GCL) catalytic subunit (GCLC) or GCL modifier subunit (GCLM) in human embryonic kidney 293 T (HEK293T) cells, led to 3- to 4-fold increase of GSH and caused 7 or 12 mV more reducing Ehc, respectively. This condition paradoxically increased the level of mitochondrial oxidation, as demonstrated by redox shifts in mitochondrial roGFP and Trx2. Lastly, either NAC treatment (EC50 4 mM) or either GCLC or GCLM overexpression exhibited increased cytotoxicity and the susceptibility to the more reducing milieu was achieved at decreased levels of ROS. Taken together, our findings reveal a novel mechanism by which GSH-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity.-Zhang, H., Limphong, P., Pieper, J., Liu, Q., Rodesch, C. K., Christians, E., Benjamin, I. J. Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity. FASEB J. 26, 1442-1451 (2012). www.fasebj.org
-
Cloning, Expression, and Biochemical Characterization of a Functionally Novel Alpha Class Glutathione S-transferase with Exceptional Activity in the Glutathione Conjugation of (+)-Anti-7,8-dihydroxy-9,10-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
H Xia,SS Pan,X Hu,SK Srivastava,A Pal,SV Singh
DOI: https://doi.org/10.1006/abbi.1998.0668
IF: 4.114
1998-01-01
Archives of Biochemistry and Biophysics
Abstract:The present study describes cDNA cloning, expression, and kinetic characterization of the two subunits of a murine alpha-class glutathione (GSH) S-transferase (GST) isoenzyme (previously designated as GST 9.5), which, unlike other alpha-class mammalian GSTs, is exceptionally efficient in the GSH conjugation of (+)-anti-7,8-dihydroxy-9,10-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene [(+)-anti-BPDE] [X. Hu, S. K. Srivastava, H. Xia, Y. C. Awasthi, and S. V. Singh (1996) J. Biol. Chem. 271, 32684-32688]. The cDNAs for both subunits of GST 9.5 (GST 9.5-1 and GST 9.5-2) were cloned by RT-PCR. The deduced amino acid sequences of GST 9.5-1 and GST 9.5-2 clones were identical to those of mGSTA1 and mGSTA2, respectively. Both these subunits were expressed in Escherichia coli to determine the relationships between recombinant mGSTA1-1 and mGSTA2-2 and corresponding subunits of tissue-isolated GST 9.5. The pI values of recombinant mGSTA1-1 and mGSTA2-2 (9.49 and 9.45, respectively) were similar to that of the tissue-isolated isoenzyme (pI 9.5). The reverse-phase HPLC elution profiles and immunological cross-reactivities of recombinant mGSTA1-1 and mGSTA2-2 were also similar to those of the corresponding subunits of tissue-isolated GST 9.5. The catalytic efficiency of recombinant mGSTA1-1 toward (+)-anti-BPDE, 131 mM-1.s-1, was approximately 9.5-to 655-fold higher compared with tissue-isolated mGSTP1-1, mGSTA3-3, mGSTM1-1, and mGSTA4-4. Moreover, the catalytic efficiency of mGSTA1-1 toward (+)-anti-BPDE was about 3.3-fold higher compared with recombinant mGSTA2-2. The mGSTA1 and/or mGSTA2 subunits were expressed to varying degrees in female A/J mouse tissues. For example, mGSTA1, but not mGSTA2, subunit expression was observed in the skin, which is a target organ for benzo(a)pyrene (BP)-induced cancer in mice. On the other hand, the expression of either mGSTA1 or mGSTA2 subunit could not be detected in the lung, which is another target organ for BP-induced cancer in mice. Interestingly, relatively large amounts of both mGSTA1 and mGSTA2 subunits were detected in the kidney. In conclusion, the results of the present study clearly indicate that the A1-type subunit of GST 9.5 is responsible for its exceptional catalytic efficiency in the GSH conjugation of (+)-anti-BPDE, which is the ultimate carcinogen of widespread environmental pollutant BP.
-
Advance in Antitumor Agents Targeting Glutathione-S-transferase.
Guisen Zhao,Xiaobing Wang
IF: 4.74
2006-01-01
Current Medicinal Chemistry
Abstract:Glutathione-S-transferases (GSTs; EC 2.5.1.18), a family of phase II detoxification enzymes, catalyze the conjugation of glutathione with broad substrates including chemotherapeutic agents, and are involved in cell protection against apoptotic signals by inhibiting the stress-signaling cascade mediated by ASK1 (Apoptosis signal-regulating kinase)-JNK (c-Jun N-terminal kinase). As GSTs are overexpressed in some malignant tumors, GSTs is a promising therapeutic target. This article reviews the progress in the development of GSTs inhibitors and GSTs activated prodrugs.
-
GSTpi Reduces DNA Damage and Cell Death by Regulating the Ubiquitination and Nuclear Translocation of NBS1.
Jinyi Zhou,Lili Gu,Yingying Shi,Ting Huang,Xirui Fan,Xiaowen Bi,Shuai Lu,Juanjuan Liang,Lan Luo,Peng Cao,Zhimin Yin
DOI: https://doi.org/10.1007/s00018-021-04057-5
IF: 8
2021-01-01
Cellular and Molecular Life Sciences
Abstract:Glutathione S-transferase pi (GSTpi) is an important phase II detoxifying enzyme that participates in various physiological processes, such as antioxidant, detoxification, and signal transduction. The high expression level of GSTpi has been reported to be related to drug-resistant and anti-inflammatory and it functioned via its non-catalytic ligandin. However, the previous protection mechanism of GSTpi in DNA damage has not been addressed so far. Nijmegen breakage syndrome 1 (NBS1) is one of the most important sensor proteins to detect damaged DNA. Here, we investigated the interaction between GSTpi and NBS1 in HEK-293 T cells and human breast adenocarcinoma cells during DNA damage. Our results showed that overexpression of GSTpi in cells by transfecting DNA vector decreased the DNA damage level after methyl methanesulfonate (MMS) or adriamycin (ADR) treatment. We found that cytosolic GSTpi could increase NBS1 ubiquitin-mediated degradation in unstimulated cells, which suggested that GSTpi could maintain the basal level of NBS1 during normal conditions. In response to DNA damage, GSTpi can be phosphorylated in Ser184 and inhibit the ubiquitination degradation of NBS1 mediated by Skp2 to recover NBS1 protein level. Phosphorylated GSTpi can further enhance NBS1 nuclear translocation to activate the ATM-Chk2-p53 signaling pathway. Finally, GSTpi blocked the cell cycle in the G2/M phase to allow more time for DNA damage repair. Thus, our finding revealed the novel mechanism of GSTpi via its Ser184 phosphorylation to protect cells from cell death during DNA damage and it enriches the function of GSTpi in drug resistance.
-
A ligand function of glutathione S-transferase
Barbara Lederer,Peter Böger
DOI: https://doi.org/10.1515/znc-2005-3-403
Abstract:Glutathione S-transferases (GSTs) are ubiquitous enzymes and abundant in plants. They are intimately involved in plant metabolism and stress defense related to reactive oxygen species. Our project assigned particular reactions including novel ones to certain GST-isoforms. Transformed E. coli was used to express recombinant GST-isoforms from maize. An N-terminal His tag allowed their purification by affinity chromatography. Three GST-monomers had a molecular weight of 26, 27, 29 kDa, and aggregated to dimers when assayed for their enzymic properties. Four dimeric isoforms were used to study how they interact with tetrapyrroles (of the chlorophyll biosynthesis pathway). It was found that protoporphyrin IX (Proto IX), Mg-protoporphyrin and other tetrapyrroles are bound non-covalently ("liganded") to GSTs but not conjugated with reduced glutathione. This binding is non-covalent, and results in inhibition of conjugation activity, the degree depends on type of the porphyrin and GST-isoform. I50-values between 1-10 microM were measured for Proto IX, the inhibition by mesoporphyrin and Mg-protoporphyrin was 2- to 5-fold less. The ligand binding is noncompetitive for the substrate 1-chloro-2,4-dinitrobenzene and competitive for glutathione. The dimer GST 26/26 prevents the (non-enzymic) autoxidation of protoporphyrinogen to Proto IX, which produces phytotoxic reactive oxygen species in the light. GST 27/27 protects hemin against degradation. Protoporphyrinogen is formed in the plastid and then exported into the cytosol. Apparently binding by a suitable GST-isoform ensures that the highly autoxidizable protoporphyrinogen can safely reach the mitochondrium where it is processed to cytochrome.
-
Are glutathione S transferases involved in DNA damage signalling? Interactions with DNA damage and repair revealed from molecular epidemiology studies
Maria Dusinska,Marta Staruchova,Alexandra Horska,Bozena Smolkova,Andrew Collins,Stefano Bonassi,Katarina Volkovova
DOI: https://doi.org/10.1016/j.mrfmmm.2012.03.003
2012-08-01
Abstract:Glutathione S-transferases (GSTs) are members of a multigene family of isoenzymes that are important in the control of oxidative stress and in phase II metabolism. Acting non-enzymically, GSTs can modulate signalling pathways of cell proliferation, cell differentiation and apoptosis. Using a molecular epidemiology approach, we have investigated a potential involvement of GSTs in DNA damage processing, specifically the modulation of DNA repair in a group of 388 healthy adult volunteers; 239 with at least 5 years of occupational exposure to asbestos, stone wool or glass fibre, and 149 reference subjects. We measured DNA damage in lymphocytes using the comet assay (alkaline single cell gel electrophoresis): strand breaks (SBs) and alkali-labile sites, oxidised pyrimidines with endonuclease III, and oxidised purines with formamidopyrimidine DNA glycosylase. We also measured GST activity in erythrocytes, and the capacity for base excision repair (BER) in a lymphocyte extract. Polymorphisms in genes encoding three GST isoenzymes were determined, namely deletion of GSTM1 and GSTT1 and single nucleotide polymorphism Ile105Val in GSTP1. Consumption of vegetables and wine correlated negatively with DNA damage and modulated BER. GST activity correlated with oxidised bases and with BER capacity, and differed depending on polymorphisms in GSTP1, GSTT1 and GSTM1. A significantly lower BER rate was associated with the homozygous GSTT1 deletion in all asbestos site subjects and in the corresponding reference group. Multifactorial analysis revealed effects of sex and exposure in GSTP1 Ile/Val heterozygotes but not in Ile/Ile homozygotes. These variants affected also SBs levels, mainly by interactions of GSTP1 genotype with exposure, with sex, and with smoking habit; and by an interaction between sex and smoking. Our results show that GST polymorphisms and GST activity can apparently influence DNA stability and repair of oxidised bases, suggesting a potential new role for these proteins in DNA damage processing via DNA damage signalling.
-
Active Site Architecture of Polymorphic Forms of Human GlutathioneS-Transferase P1-1 Accounts for Their Enantioselectivity and Disparate Activity in the Glutathione Conjugation of 7β,8α-Dihydroxy-9α, 10α-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene
Xun Hu,Rosemary O'donnell,Sanjay K. Srivastava,Hong Xia,Piotr Zimniak,Bindu Nanduri,Richard J. Bleicher,Sanjay Awasthi,Yogesh C. Awasthi,Xinhua Ji,Shivendra V. Singh
DOI: https://doi.org/10.1006/bbrc.1997.6777
IF: 3.1
1997-01-01
Biochemical and Biophysical Research Communications
Abstract:In this study, we demonstrate that the active site architecture of the human glutathione (GSH) S-transferase Pi (GSTP1-1) accounts for its enantioselectivity in the GSH conjugation of 7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-oxy-7,8,9,10-tetrahydrobenzo(a) pyrene (anti-BPDE), the ultimate carcinogen of benzo(a)pyrene. Furthermore, we report that the two polymorphic forms of human GSTP1-1, differing in their primary structure by a single amino acid in position 104, have disparate activity toward (+)-anti-BPDE, which can also be rationalized in terms of their active site structures. When concentration of (+)-anti-BPDE, which among four BPDE isomers is the most potent carcinogen, was varied and GSH concentration was kept constant at 2 mM (saturating concentration), both forms of hGSTP1-1 [hGSTP1-1(V104) and hGSTP1-1(I104)] obeyed Michaelis-Menten kinetics. The V-max of GSH conjugation of (+)-anti-BPDE was approximately 3.4 fold higher for hGSTP1-1(V104) than for hGSTP1-1(I104). Adherence to Michaelis-Menten kinetics was also observed for both isoforms when (-)-anti-BPDE, which is a weak carcinogen, was used as the variable substrate. However, (-)-anti-BPDE was a relatively poor substrate for both isoforms as compared with (+)-anti-BPDE. Moreover, there were no significant differences between hGSTP1-1(V104) and hGSTP1-1(I104) in either V-max or K-m for (-)-anti-BPDE. The mechanism of differences in kinetic properties and enantioselectivity of hGSTP1-1 variants toward anti-BPDE was investigated by modeling of the two proteins with conjugation product molecules in their active sites. Molecular modeling studies revealed that the differences in catalytic properties of hGSTP1-1 variants as well as the enantioselectivity of hGSTP1-1 in the GSH conjugation of anti-BPDE can be rationalized in terms of the architecture of their active sites. Our results suggest that the population polymorphism of hGSTP1-1 variants with disparate enzyme activities may, at least in part, account for the differential susceptibility of individuals to carcinogens such as anti-BPDE and possibly other similar carcinogens. (C) 1997 Academic Press.
-
Overexpression of Glutathione S-Transferases in Human Diseases: Drug Targets and Therapeutic Implications
Ning Lv,Chunyan Huang,Haoyan Huang,Zhiqiang Dong,Xijing Chen,Chengcan Lu,Yongjie Zhang
DOI: https://doi.org/10.3390/antiox12111970
IF: 7.675
2023-01-01
Antioxidants
Abstract:Glutathione S-transferases (GSTs) are a major class of phase II metabolic enzymes. Besides their essential role in detoxification, GSTs also exert diverse biological activities in the occurrence and development of various diseases. In the past few decades, much research interest has been paid to exploring the mechanisms of GST overexpression in tumor drug resistance. Correspondingly, many GST inhibitors have been developed and applied, solely or in combination with chemotherapeutic drugs, for the treatment of multi-drug resistant tumors. Moreover, novel roles of GSTs in other diseases, such as pulmonary fibrosis and neurodegenerative diseases, have been recognized in recent years, although the exact regulatory mechanisms remain to be elucidated. This review, firstly summarizes the roles of GSTs and their overexpression in the above-mentioned diseases with emphasis on the modulation of cell signaling pathways and protein functions. Secondly, specific GST inhibitors currently in pre-clinical development and in clinical stages are inventoried. Lastly, applications of GST inhibitors in targeting cell signaling pathways and intracellular biological processes are discussed, and the potential for disease treatment is prospected. Taken together, this review is expected to provide new insights into the interconnection between GST overexpression and human diseases, which may assist future drug discovery targeting GSTs.